Printer's No. PN1960
See other bills
under the
same topic PRINTER'S NO. 1960 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.262 Session of 2025 INTRODUCED BY SHUSTERMAN, HILL-EVANS, PIELLI, RIVERA, SANCHEZ, HANBIDGE, CEPEDA-FREYTIZ, MAYES, GILLEN, HOHENSTEIN, PARKER, D. WILLIAMS AND MADDEN, JUNE 17, 2025 REFERRED TO COMMITTEE ON HEALTH, JUNE 18, 2025 A RESOLUTIONDesignating the month of October 2025 as "Menopause Awareness Month" in Pennsylvania.WHEREAS, Menopause is the stage of a woman's life that is reached after 12 consecutive months have passed without a menstrual period; andWHEREAS, For many women, menopause is a natural, biological process, though induced menopause can be caused by surgery or medical treatments; andWHEREAS, Women generally achieve menopause between 45 and 55 years of age, after experiencing the transition through perimenopause during the 8 to 10 years prior; andWHEREAS, Once menopause is achieved, it signals that a woman's ovaries have stopped producing reproductive hormones and a woman enters the postmenopausal stage for the remainder of her life; andWHEREAS, Common symptoms of menopause include weight gain, joint and muscle pain, brain fog, increased risk of depression 1234567891011121314151617 and anxiety, hot flashes and night sweats, sleep disturbances, changes in sexual function, bone loss, changing cholesterol levels and vaginal and bladder complications; andWHEREAS, Most women notice a reduction in their symptoms postmenopause, while others may still experience some symptoms for several years; andWHEREAS, From the point of menopause to 60 years of age, most women lose up to 25% of their bone mass due to the effects of low estrogen; andWHEREAS, Due to low estrogen levels, postmenopausal women have an increased risk for osteoporosis and cardiovascular diseases; andWHEREAS, Available treatments for the symptoms of menopause include hormone replacement therapy, strength training, medication and dietary and lifestyle adjustments; andWHEREAS, Prevention measures to reduce a woman's risk of developing osteoporosis and heart disease associated with menopause include hormone replacement therapy, screenings via medical practitioners for bone density and heart health and dietary and lifestyle changes; andWHEREAS, Studies have found that almost half of women under 40 years of age reported not being informed at all about menopause, and many had only begun looking for information about it once their symptoms had already started; andWHEREAS, Many obstetric and gynecology residency programs do not have a designated menopause curriculum; andWHEREAS, Most women do not receive bone density screenings until 65 years of age or older; andWHEREAS, More education and awareness must be made available to women, medical professionals and the general public about the 20250HR0262PN1960 - 2 - 123456789101112131415161718192021222324252627282930 symptoms, preventative treatments and risks of menopause and the postmenopausal stage of women's lives so that women can feel empowered to take control of their long-term health and well-being; therefore be itRESOLVED, That the House of Representatives designate the month of October 2025 as "Menopause Awareness Month" in Pennsylvania.20250HR0262PN1960 - 3 - 1234567
under the
same topic PRINTER'S NO. 1960 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.262 Session of 2025 INTRODUCED BY SHUSTERMAN, HILL-EVANS, PIELLI, RIVERA, SANCHEZ, HANBIDGE, CEPEDA-FREYTIZ, MAYES, GILLEN, HOHENSTEIN, PARKER, D. WILLIAMS AND MADDEN, JUNE 17, 2025 REFERRED TO COMMITTEE ON HEALTH, JUNE 18, 2025 A RESOLUTIONDesignating the month of October 2025 as "Menopause Awareness Month" in Pennsylvania.WHEREAS, Menopause is the stage of a woman's life that is reached after 12 consecutive months have passed without a menstrual period; andWHEREAS, For many women, menopause is a natural, biological process, though induced menopause can be caused by surgery or medical treatments; andWHEREAS, Women generally achieve menopause between 45 and 55 years of age, after experiencing the transition through perimenopause during the 8 to 10 years prior; andWHEREAS, Once menopause is achieved, it signals that a woman's ovaries have stopped producing reproductive hormones and a woman enters the postmenopausal stage for the remainder of her life; andWHEREAS, Common symptoms of menopause include weight gain, joint and muscle pain, brain fog, increased risk of depression 1234567891011121314151617 and anxiety, hot flashes and night sweats, sleep disturbances, changes in sexual function, bone loss, changing cholesterol levels and vaginal and bladder complications; andWHEREAS, Most women notice a reduction in their symptoms postmenopause, while others may still experience some symptoms for several years; andWHEREAS, From the point of menopause to 60 years of age, most women lose up to 25% of their bone mass due to the effects of low estrogen; andWHEREAS, Due to low estrogen levels, postmenopausal women have an increased risk for osteoporosis and cardiovascular diseases; andWHEREAS, Available treatments for the symptoms of menopause include hormone replacement therapy, strength training, medication and dietary and lifestyle adjustments; andWHEREAS, Prevention measures to reduce a woman's risk of developing osteoporosis and heart disease associated with menopause include hormone replacement therapy, screenings via medical practitioners for bone density and heart health and dietary and lifestyle changes; andWHEREAS, Studies have found that almost half of women under 40 years of age reported not being informed at all about menopause, and many had only begun looking for information about it once their symptoms had already started; andWHEREAS, Many obstetric and gynecology residency programs do not have a designated menopause curriculum; andWHEREAS, Most women do not receive bone density screenings until 65 years of age or older; andWHEREAS, More education and awareness must be made available to women, medical professionals and the general public about the 20250HR0262PN1960 - 2 - 123456789101112131415161718192021222324252627282930 symptoms, preventative treatments and risks of menopause and the postmenopausal stage of women's lives so that women can feel empowered to take control of their long-term health and well-being; therefore be itRESOLVED, That the House of Representatives designate the month of October 2025 as "Menopause Awareness Month" in Pennsylvania.20250HR0262PN1960 - 3 - 1234567
Texto oficial de la Legislatura de Pennsylvania. El formato se adaptó para leerlo en Ratifi.